Patents by Inventor Kevin M. Friedman

Kevin M. Friedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LYMPHOCYTE TARGETED LENTIVIRAL VECTORS
    Publication number: 20240218390
    Abstract: Provided herein are lentiviral vectors comprising a mutated, heterologous envelope protein, a targeting protein, and at least one transgene for delivery to and expression by a cell characterized by the targeting protein. Also provided are methods and materials for producing the lentiviral vectors described herein, methods for transducing target cells, and cells transduced by lentiviral vectors according to the present disclosure.
    Type: Application
    Filed: February 25, 2022
    Publication date: July 4, 2024
    Inventors: Molly R. Perkins, Kevin M. Friedman
  • LYMPHOCYTE TARGETED LENTIVIRAL VECTORS
    Publication number: 20240150788
    Abstract: Provided herein are lentiviral vectors comprising a mutated, heterologous envelope protein, a targeting protein, and at least one transgene for delivery to and expression by a cell characterized by the targeting protein. Also provided are methods and materials for producing the lentiviral vectors described herein, methods for transducing target cells, and cells transduced by lentiviral vectors according to the present disclosure.
    Type: Application
    Filed: October 2, 2023
    Publication date: May 9, 2024
    Inventors: Molly R. Perkins, Kevin M. Friedman